Nexalin Technology, Inc. Common Stock (NXL) is a publicly traded Healthcare sector company. As of May 19, 2026, NXL trades at $0.32 with a market cap of $7.05M and a P/E ratio of -0.67. NXL moved +0.00% today. Year to date, NXL is -44.30%; over the trailing twelve months it is -74.45%. Its 52-week range spans $0.31 to $4.49. Analyst consensus is buy with an average price target of $2.00. Rallies surfaces NXL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Nexalin Technology, Inc. Common Stock (NXL) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NXL moved +0.00% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $0.32 |
| Market Cap | $7.05M |
| P/E Ratio | -0.67 |
| EPS | $-0.47 |
| Dividend Yield | 0.31% |
| 52-Week High | $4.49 |
| 52-Week Low | $0.31 |
| Volume | 534.66K |
| Avg Volume | 0 |
| Revenue (TTM) | $275.58K |
| Net Income | $-8.33M |
| Gross Margin | 81.99% |
1 analysts cover NXL: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.00.